Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
266M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
53M
-
Shares change
-
+740K
-
Total reported value, excl. options
-
$577M
-
Value change
-
-$2.37M
-
Put/Call ratio
-
4.9
-
Number of buys
-
72
-
Number of sells
-
-77
-
Price
-
$10.88
Significant Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) as of Q3 2023
179 filings reported holding OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q3 2023.
Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53M shares
of 266M outstanding shares and own 19.95% of the company stock.
Largest 10 shareholders include FMR LLC (7.47M shares), JPMORGAN CHASE & CO (5.11M shares), VANGUARD GROUP INC (4.77M shares), BlackRock Inc. (3.72M shares), T. Rowe Price Investment Management, Inc. (3.17M shares), Bellevue Group AG (2.41M shares), BRAIDWELL LP (2.4M shares), Champlain Investment Partners, LLC (1.93M shares), AMERIPRISE FINANCIAL INC (1.75M shares), and MORGAN STANLEY (1.6M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.